A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 1,924 shares of MEDP stock, worth $879,268. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,924
Previous 1,185 62.36%
Holding current value
$879,268
Previous $393,000 49.11%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$304.69 - $360.97 $225,165 - $266,756
739 Added 62.36%
1,924 $586,000
Q4 2024

Feb 14, 2025

BUY
$308.93 - $363.58 $366,082 - $430,842
1,185 New
1,185 $393,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $14.2B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.